EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Pseudohyperphosphatemia related to a monoclonal immunoglobulin in a patient with plasma cell leukemia: an analytical interference to be aware of

Morgane Ducastel, Natalia Ermak, Ismaël Boussaid, Frédéric Pène, Didier Borderie

Annales de Biologie Clinique · 2025

DOI: 10.1684/abc.2025.2013 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annales de Biologie Clinique, 2025. Verfasst von Morgane Ducastel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Deparment of Biochemistry, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Hyperphosphatemia, Leukemia, Plasma Cell.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a case of pseudohyperphosphatemia in a patient with multiple myeloma that progressed to plasma cell leukaemia. This pseudohyperphosphatemia was caused by an analytical interference between monoclonal immunoglobulin and ammonium molybdate, a reagent used for measuring inorganic phosphate. Accurate measurement of blood inorganic phosphate levels requires prior protein precipitation to eliminate assay interference. Extrarenal purification treatments helped reduce the monoclonal immunoglobulin concentration and eliminated the interference during phosphate measurement. Pseudohyperphosphatemia is a rare event that can lead to inappropriate and harmful medical management for affected patients; thus, prompt recognition by clinical biologists is crucial to avoid misdiagnosis and inappropriate interventions. This case report also provides an opportunity to do a brief review of the literature and to remind some recommendations and actions to take into consideration in the presence of discrepancies between the clinic and the biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalHyperphosphatemiaLeukemia, Plasma CellHumansMolybdenumMultiple MyelomaPhosphates

Stichwörter der Autor:innen

ammonium molybdatemonoclonal immunoglobulinmultiple myelomaplasma cell leukaemiapseudohyperphosphatemia

Substanzen

Antibodies, MonoclonalMolybdenumPhosphates

Autor:innen und Institutionen

  • Deparment of Biochemistry, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France.
  • Deparment of Immunology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France.
  • Deparment of Biological Hematology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France.
  • Intensive Care Unit, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France, Inserm UMRs 1016, CNRS UMR8104, Institut Cochin, Université Paris Cité, Paris, France.
  • Deparment of Biochemistry, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France, Inserm UMRs 1124 HealthFex (Health and Functional Exposomics), Paris Cité University, Paris, Franc…

Zitieren

APA

Ducastel, M., Ermak, N., Boussaid, I., Pène, F., & Borderie, D. (2025). Pseudohyperphosphatemia related to a monoclonal immunoglobulin in a patient with plasma cell leukemia: an analytical interference to be aware of. Annales de Biologie Clinique. https://doi.org/10.1684/abc.2025.2013

Vancouver

Ducastel M, Ermak N, Boussaid I, Pène F, Borderie D. Pseudohyperphosphatemia related to a monoclonal immunoglobulin in a patient with plasma cell leukemia: an analytical interference to be aware of. Annales de Biologie Clinique. 2025. doi:10.1684/abc.2025.2013

BibTeX
@article{Ducastel2025,
  author = {Ducastel, Morgane and Ermak, Natalia and Boussaid, Ismaël and Pène, Frédéric and Borderie, Didier},
  title = {Pseudohyperphosphatemia related to a monoclonal immunoglobulin in a patient with plasma cell leukemia: an analytical interference to be aware of},
  journal = {Annales de Biologie Clinique},
  year = {2025},
  doi = {10.1684/abc.2025.2013}
}
Kostenlos starten →